Ibbotson S H
Photobiology Unit, University Department of Dermatology, Tayside University Hospitals NHS Trust, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK.
Br J Dermatol. 2002 Feb;146(2):178-88. doi: 10.1046/j.0007-0963.2001.04689.x.
Topical 5-aminolaevulinic acid (ALA) photodynamic therapy (PDT) is used increasingly for superficial non-melanoma skin cancer (NMSC) and dysplasia. However, the relative accumulation of the photosensitizer protoporphyrin IX (PpIX) in diseased tissue is not specific for neoplastic disease, and has been shown after the application of ALA to benign proliferative skin conditions such as viral warts and psoriasis. This review appraises the quality of evidence available for the use of topical ALA-PDT in the treatment of skin conditions other than NMSC. The diseases that have been studied in most detail are recalcitrant viral warts, acne, psoriasis and cutaneous T-cell lymphoma. Publications relating to the treatment of other diseases by topical PDT are restricted to small case series or case reports. The relevant literature will be discussed and the potential for topical PDT in the treatment of several skin diseases is highlighted, although more detailed studies are required to clarify the role of PDT beyond the treatment of NMSC.
局部应用5-氨基酮戊酸(ALA)光动力疗法(PDT)越来越多地用于浅表性非黑素瘤皮肤癌(NMSC)和发育异常。然而,光敏剂原卟啉IX(PpIX)在病变组织中的相对蓄积并非肿瘤性疾病所特有,并且在将ALA应用于良性增生性皮肤病如病毒疣和银屑病后也已得到证实。本综述评估了局部应用ALA-PDT治疗除NMSC以外的皮肤疾病的现有证据质量。研究最详细的疾病是顽固性病毒疣、痤疮、银屑病和皮肤T细胞淋巴瘤。关于局部PDT治疗其他疾病的出版物仅限于小病例系列或病例报告。将讨论相关文献,并强调局部PDT在治疗几种皮肤疾病中的潜力,尽管需要更详细的研究来阐明PDT在治疗NMSC以外疾病中的作用。